Chronic Hepatitis in Dogs: Long-Term Welfare Management

Chronic hepatitis is a significant cause of liver disease in dogs requiring accurate diagnosis and long-term management to maintain quality of life.

Key Facts

Chronic hepatitis involves ongoing hepatic inflammation and progressive fibrosis
Copper-associated hepatitis is most common in Bedlington Terriers, Labradors, and Dalmatians
Immune-mediated hepatitis may respond to immunosuppressive therapy with prednisolone
S-adenosylmethionine (SAMe) and milk thistle (silybin) support liver function and reduce oxidative damage
Dietary copper restriction is critical in copper-associated hepatitis
Liver biopsy distinguishes hepatitis from other hepatopathies and guides treatment
Regular monitoring of liver enzymes, bile acids, and albumin tracks disease progression

Welfare Considerations

Chronic hepatitis progresses silently until significant liver function is lost. Dogs with established liver failure experience nausea, reduced appetite, jaundice, fluid accumulation, and neurological signs from hepatic encephalopathy - all welfare-significant consequences of advanced disease. Early diagnosis through routine liver enzyme monitoring in predisposed breeds enables intervention before severe damage occurs. Long-term management with appropriate diet, hepatoprotectants, and specific therapy where indicated maintains quality of life for extended periods.

What You Can Do

Screen predisposed breeds for liver disease with annual liver enzyme panels from age 2
Pursue liver biopsy for accurate diagnosis when elevated enzymes are detected - type determines treatment
Implement dietary copper restriction in breeds with copper-associated hepatitis
Administer hepatoprotectant supplements (SAMe, silybin) as part of a chronic hepatitis management plan
Monitor liver function markers regularly to detect progression and guide treatment adjustments